Evidence map›Paper›PMID 28752285›Full record

ReviewCurrent HIV/AIDS reports2017

HIV Prevention Among Transgender Populations: Knowledge Gaps and Evidence for Action.

Tonia Poteat, Mannat Malik, Ayden Scheim, Ayana Elliott

Erratum issuedAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 66 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Barriers and Facilitators to HPV Vaccination Completion among Transgender Women in Mexico: Implications for HPV Prevention and Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  13. Article
  14. Article
  15. Intersectional Barriers Among PLHIV in Rural Illinois: Insights from a Pilot QCA Study.International journal of environmental research and public health · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Tonia PoteatDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, E7138, Baltimore, MD, 21205, USA. tpoteat@jhu.edu.
Mannat MalikDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, E7138, Baltimore, MD, 21205, USA.
Ayden ScheimDepartment of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, The University of Western Ontario, K201 Kresge Building, London, ON, N6B 3J6, Canada.
Ayana ElliottDirector of Clinical Operations, City of Hope South Pasadena, 209 Fair Oaks Avenue, South Pasadena, CA, 91030, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

purpose of reviewThe purpose of this review is to summarize the available evidence-based HIV prevention interventions tailored for transgender people. RECENT

findingsA limited number of evidence-based HIV prevention interventions have been tested with transgender populations. Most existing interventions target behavior change among transgender women, with only one HIV prevention program evaluated for transgender men. Studies addressing biomedical interventions for transgender women are ongoing. Few interventions address social and structural barriers to HIV prevention, such as stigma, discrimination, and poverty. Evidence-based multi-level interventions that address the structural, biomedical, and behavioral risks for HIV among transgender populations, including transgender men, are needed to address disparities in HIV prevalence. Future research should address not only pre-exposure prophylaxis uptake and condom use but also structural barriers that limit access to these prevention strategies.

Indexed as

Health Knowledge, Attitudes, PracticeTransgender PersonsFemaleHIV InfectionsHumansMalePre-Exposure ProphylaxisSafe SexBehavioral interventionsBiomedical interventionsHIV preventionStigmaStructural determinantsTransgender

Identifiers

PMID28752285
PMCPMC5896563

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.